Corbion N.V Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/9/2026)
| Balance Sheet | Total Assets | 1,416,900,000.00 | ROE | 52.41 % |
| Balance Sheet | Total Equity | 742,600,000.00 | ROA | 5.28 % |
| Cashflow | Capital Expenditures | -68,200,000.00 | P/FCF | 14.44 |
| Cashflow | Free Cash Flow | 92,700,000.00 | – | – |
| Cashflow | Operating Cash Flow | 160,900,000.00 | P/CF | 8.32 |
| Income | Earnings per Share (diluted) | 1.29 | Div. Yield | 2.77 % |
| Income | Net Income | 74,800,000.00 | P/E | 17.89 |
| Income | Shares Outstanding | 57,987,700.00 | P/B | 1.80 |
| Income | Total Revenue | 1,267,400,000.00 | P/S | 1.06 |
Ratios calculated on: 10/14/2026
Company Description
Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and personal care, animal nutrition, pharmaceutical, medical device, and bioplastics markets. It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.corbion.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more